Disclosures for "Novel Bispecific Degrader BHV-1310 Achieves Rapid, Robust, and Selective IgG Reduction in Preclinical Models including Nonhuman Primates"
-
Simone Nicholson has received personal compensation for serving as an employee of Biohaven. Simone Nicholson has stock in Biohaven.
-
Elizabeth Dierks has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Elizabeth Dierks has stock in Biohaven Pharmaceuticals. Elizabeth Dierks has stock in Bristol-Myers Squibb.
-
Wes Kazmierski has received personal compensation for serving as an employee of Biohaven Phamaceuticals. Wes Kazmierski has stock in Biohaven Pharmaceuticals. Wes Kazmierski has received intellectual property interests from a discovery or technology relating to health care.
-
Mr. Poole has received personal compensation for serving as an employee of Allucent .
-
Gene Dubowchik has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Gene Dubowchik has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Morrison Foerster.
-
David Pirman has received personal compensation for serving as an employee of Biohaven. David Pirman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Scaffold Tx. David Pirman has stock in Agios.
-
David Spiegel has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for Biohaven. David Spiegel has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Magnet Biotherapeutics. David Spiegel has stock in Biohaven. David Spiegel has stock in Magnet Biotherapeutics. The institution of David Spiegel has received research support from Biohaven. David Spiegel has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Bunin has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Dr. Bunin has stock in Biohaven Pharmaceuticals. Dr. Bunin has received intellectual property interests from a discovery or technology relating to health care.
-
Neal Sharpe has nothing to disclose.
-
Author has nothing to disclose
-
Dr. Car has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Dr. Car has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PathAI. Dr. Car has stock in BHVN. Dr. Car has received intellectual property interests from a discovery or technology relating to health care.